68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

NCT02038738 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine
Neuroendocrine Tumor
Neuroendocrine Cancer
Neuroendocrine Carcinoma
Carcinoid
Carcinoid Tumor
Islet Cell Tumor
Apudoma

Interventions

DRUG: 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.

Sponsor

Ochsner Health System